Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Private equity
Biotech
Jeito's $1.2B ‘largest ever’ for independent Euro biopharma fund
Jeito Capital has hailed the $1.2 billion it has secured as the “largest raise ever achieved” by an independent biopharma-focused European fund.
James Waldron
Apr 8, 2026 5:01am
Hologic to go private with $18.3B deal by Blackstone and TPG
Oct 22, 2025 8:45am
PE dealmaking, exit counts on the rise in Q3: PitchBook
Oct 20, 2025 5:05pm
Private equity firm acquires site network Headlands Research
Aug 18, 2025 1:53pm
Investor syndicate takes majority stake in HistoSonics
Aug 7, 2025 1:16pm
ZimVie to be bought by ArchiMed in $730M deal
Jul 21, 2025 11:45am
